Good Reads #2: Industry 4.0 and South Korea as the main powerhouse of biosimilars

Pharma cold chain logistics is very complex with many stakeholders involved. We all work hard to ensure that pharmaceuticals maintain optimal quality all the way to the patients. At Envirotainer we believe that the best way to reach our common goal is to improve collaboration and mutual understanding across the logistics chain, we call it our eco-system thinking. Here, we share articles with our network that we think could benefit us all.

This week’s Good Reads covers two trends in the pharmaceutical industry – Industry 4.0 and the fact that South Korea has started pumping out enormous volumes of biosimilars (cheaper versions of biopharmaceuticals with expired patents).

Next Generation Manufacturing

Industry 4.0 (also called next generation manufacturing) refers to the new advancements in manufacturing with a high degree of automation, process control, process integration with suppliers and modular design. The result is significantly reduced defects, reduced production costs and reduced manpower requirements. Tim Alosi, Head of Global Data Analytics at Biogen, describes Biogen’s next generation manufacturing facility in Switzerland and the huge number of partners that have made it possible.

Read More

South Korea

APAC has become one of the leading regions for the development and manufacturing of biosimilars. South Korea is now emerging as the main powerhouse, with leading biosimilar giants such as Samsung Bioepis and Celltrion. Did you know that two out of three biosimilars sold worldwide last year were South Korean products? The two articles here give some interesting details about the South Korean biosimilars success story.

Leading biosimilars opportunities for Asia

Read More

Emerging as the biosimilars bowl of the world

Read More

Related Articles

Top 5 benefits of an active cold chain in pharma air freight

Global pharmaceutical regulatory requirements are becoming more strict and are beginning to extend into the transportation of pharmaceutical goods. Accordingly, airlines specializing in pharma transportation must offer logistics services that match those higher demands. For temperature-sensitive products, active cold chain packaging solutions are the safest choice and provide a means for airlines to build a strong brand.

6 global pharma trends that affect cold chain air freight

Pharmaceutical cold chain is a growing business area for many airlines but it is also under pressure due to changes in the pharmaceutical industry. Airline companies that want to maintain and expand their business with pharma need to be updated on what is happening in the industry in order to build a strong brand. Here are six global trends to keep an eye on.

Active Cold Chain Membership

Stay informed! Sign up to become an Active Cold Chain Member.

Sign Up

Was this information helpful?